Home/Recalls/FDA-D-0245-2026
FDA DrugsClass II

Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14

Published: January 7, 2026Recall ID: D-0245-2026Category: drugsCountry: US
US
PharmaceuticalFDA DrugsUSUS

Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14

Recalling Firm: Novo Nordisk Inc.

Reason for Recall / Hazard

Presence of Particulate Matter: Hair was found in a prefilled syringe

Product Description & Identification

Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14

Additional Source Details

FieldValue
CityPlainsboro
StateNJ
Openfda › Nui › 1N0000178480
Openfda › Nui › 2M0160181
Openfda › Nui › 3N0000020058
Openfda › Unii53AXN4NNHX
Openfda › RouteSUBCUTANEOUS
Openfda › Spl idf38985f6-b16a-426b-9c0d-6d4815acebfe
Openfda › Brand nameWEGOVY
Openfda › Spl set idee06186f-2aa3-4990-a760-757579d8f77b
Openfda › Package ndc › 10169-4525-01
Openfda › Package ndc › 20169-4525-14
Openfda › Package ndc › 30169-4525-90
Openfda › Package ndc › 40169-4525-94
Openfda › Package ndc › 50169-4505-01
Openfda › Package ndc › 60169-4505-14
Openfda › Package ndc › 70169-4501-01
Openfda › Package ndc › 80169-4501-14
Openfda › Package ndc › 90169-4517-01
Openfda › Package ndc › 100169-4517-14
Openfda › Package ndc › 110169-4524-01
Openfda › Package ndc › 120169-4524-14
Openfda › Package ndc › 130169-4572-01
Openfda › Package ndc › 140169-4572-14
Openfda › Package ndc › 150169-1602-01
Openfda › Package ndc › 160169-1602-14
Openfda › Package ndc › 170169-1602-90
Openfda › Package ndc › 180169-1602-94
Openfda › Package ndc › 190169-1605-01
Openfda › Package ndc › 200169-1605-14
Openfda › Package ndc › 210169-1610-01
Openfda › Package ndc › 220169-1610-14
Openfda › Package ndc › 230169-1617-01
Openfda › Package ndc › 240169-1617-14
Openfda › Package ndc › 250169-1624-01
Openfda › Package ndc › 260169-1624-14
Openfda › Package ndc › 270169-4915-32
Openfda › Package ndc › 280169-4915-03
Openfda › Package ndc › 290169-4404-31
Openfda › Package ndc › 300169-4415-31
Openfda › Package ndc › 310169-4415-92
Openfda › Package ndc › 320169-4409-31
Openfda › Package ndc › 330169-4425-31
Openfda › Product ndc › 10169-1602
Openfda › Product ndc › 20169-4525
Openfda › Product ndc › 30169-4505
Openfda › Product ndc › 40169-4501
Openfda › Product ndc › 50169-4517
Openfda › Product ndc › 60169-4524
Openfda › Product ndc › 70169-4572
Openfda › Product ndc › 80169-1605
Openfda › Product ndc › 90169-1610
Openfda › Product ndc › 100169-1617
Openfda › Product ndc › 110169-1624
Openfda › Product ndc › 120169-4915
Openfda › Product ndc › 130169-4404
Openfda › Product ndc › 140169-4415
Openfda › Product ndc › 150169-4409
Openfda › Product ndc › 160169-4425
Openfda › Generic nameSEMAGLUTIDE
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Pharm class csGlucagon-Like Peptide 1 [CS]
Openfda › Substance nameSEMAGLUTIDE
Openfda › Pharm class epcGLP-1 Receptor Agonist [EPC]
Openfda › Pharm class moaGlucagon-like Peptide-1 (GLP-1) Agonists [MoA]
Openfda › Manufacturer nameNovo Nordisk Pharmaceutical Industries, LP
Openfda › Application numberNDA215256
Openfda › Is original packagertrue
Event id98100
Address 1800 Scudders Mill Rd
Address 2N/A
Code infoLot #: RZFYK06, RZFYA53; Exp Date 3/31/2027
Postal code08536-1606
Report date20260107
Product typeDrugs
Product quantityN/A
Reason for recallPresence of Particulate Matter: Hair was found in a prefilled syringe
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20251219
Initial firm notificationLetter
Center classification date20251231

Check Other Products In Your Household

Free Safety Tools

Safety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:

Barcode ScannerVIN Vehicle CheckPantry Safety Audit

Overview

  • Recalling FirmNovo Nordisk Inc.
  • StatusOngoing
  • Risk LevelClass II
  • DistributionNationwide within the United States.
Recall Hazard Severity
High Alert (Class I)
Official Agency Alert

📢 Share Warning

Alert family and friends to keep them safe. Copy this quick alert message:

🚨 SAFETY ALERT: Novo Nordisk Inc. - Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14

Check if your household is affected:
https://therecallfile.com/recalls/wegovy-semaglutide-injection-1-mg-0-5-ml-4-single-dose-prefilled-pens/FDA-D-0245-2026
WhatsAppFacebook

Join Alertlist

Get instant email updates whenever critical safety recalls like this are published.

Featured on Product Hunt

Help support our public safety mission and check out our community launch.

The Recall File - The Google for Product Recalls | Product Hunt

Support The Recall File

Help keep official recall alerts free, accessible, and fast for everyone.

Donate with PayPal

Supports USD, EUR, GBP, International Cards & PayPal

Spread the WordWegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14

Related Recalls

PharmaceuticalUKUK

MHRA Safety Roundup: August 2026

MHRAUK
uk-mhraMedicines Recall

MHRA Safety Roundup: August 2026

Summary of the latest safety advice for medicines and medical device users...

Aug 25, 2026MHRA
PharmaceuticalAustraliaAustralia

CAROTONE skin-brightening products found to contain undeclared prescription-only medicine

TGAAustralia
au-tgaMedicines Safet...

CAROTONE skin-brightening products found to contain undeclared prescription-only medicine

We are advising consumers that CAROTONE products marketed for skin brightening may pose a serious risk to your health and should not be used....

Aug 24, 2026TGA
PharmaceuticalUKUK

Class 2 Medicines Recall: Zentiva Pharma UK Limited, Fingolimod Zentiva 0.5 mg Capsules, EL(26)A/37

Zentiva Pharma UK LimitedUK
uk-mhraMedicines Recall

Class 2 Medicines Recall: Zentiva Pharma UK Limited, Fingolimod Zentiva 0.5 mg Capsules, EL(26)A/37

Zentiva UK Pharma Limited are recalling one batch of Fingolimod Zentiva 0.5 mg Capsules (BN 4L01372H) as a precautionary measure due to a potential risk of contamination with metal particles....

Aug 20, 2026Zentiva Pharma UK Limited

Install The Recall File App

Check safety warnings, scan your pantry, and monitor your vehicles directly from your home screen.